Document is current
Any future updates will be listed below
-
Authors
Chisholm, Alison
Tucker, Katherine L
Crawford, Carole
Green, Marcus
Greenfield, Sheila
Hodgkinson, James
Lavallee, Layla
Leeson, Paul
Mackillop, Lucy
McCourt, Christine
Sandall, Jane
Wilson, Hannah
Chappell, Lucy C
McManus, Richard J
Hinton, Lisa
-
Funding
Funding for this research was provided by:
National Institute for Health and Care Research (RP-PG-1209-10051)
National Institute for Health and Care Research (RP-PG-1209-10051)
National Institute for Health and Care Research (RP-PG-1209-10051)
National Institute for Health and Care Research (RP-PG-1209-10051)
National Institute for Health and Care Research (RP-PG-1209-10051)
National Institute for Health and Care Research (RP-PG-1209-10051)
National Institute for Health and Care Research (RP-PG-1209-10051)
National Institute for Health and Care Research (RP-PG-1209-10051)
National Institute for Health and Care Research (RP-PG-1209-10051)
National Institute for Health and Care Research (RP-PG-1209-10051)
National Institute for Health and Care Research (RP-PG-1209-10051)
National Institute for Health and Care Research (RP-PG-1209-10051)
National Institute for Health and Care Research (RP-PG-1209-10051)
National Institute for Health and Care Research (RP-PG-1209-10051)
National Institute for Health and Care Research (RP-PG-1209-10051)
- License Information
-
More Information
Article History
Received: 31 March 2023
Accepted: 8 November 2024
First Online: 28 November 2024
Declarations
:
: Not applicable.
: RM has received BP monitors for research use from Omron and is working with them to develop a telemonitoring system for use in primary care. The telemonitoring system used in the BUMP trials was licenced to Sensyne in 2020 to allow free implementation during the pandemic and has now been licenced commercially. He receives no personal payment for such work. The remaining authors have no disclosures. LM is supported by NIHR Oxford Biomedical Research Centre and is a part-time employee of EMIS Group plc.
: The study was approved by the Research Ethics Committee (West Midlands - South Birmingham: ref 17/WM/0241), host institutions and Health Research Authority. All participants gave written informed consent before taking part. The protocol was performed in accordance with the relevant guidelines and regulations [Declaration of Helsinki].
